225 related articles for article (PubMed ID: 31288422)
1. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
Isakova-Sivak I; Matyushenko V; Kotomina T; Kiseleva I; Krutikova E; Donina S; Rekstin A; Larionova N; Mezhenskaya D; Sivak K; Muzhikyan A; Katelnikova A; Rudenko L
Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31288422
[TBL] [Abstract][Full Text] [Related]
2. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
Korenkov DA; Laurie KL; Reading PC; Carolan LA; Chan KF; Isakova-Sivak II; Smolonogina TA; Subbarao K; Barr IG; Villanueva J; Shcherbik S; Bousse T; Rudenko LG
Infect Genet Evol; 2018 Oct; 64():95-104. PubMed ID: 29929009
[TBL] [Abstract][Full Text] [Related]
3. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
4. Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
Isakova-Sivak I; Korenkov D; Smolonogina T; Kotomina T; Donina S; Matyushenko V; Mezhenskaya D; Krammer F; Rudenko L
Virology; 2018 May; 518():313-323. PubMed ID: 29574336
[TBL] [Abstract][Full Text] [Related]
5. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
Shcherbik S; Carney P; Pearce N; Stevens J; Dugan VG; Wentworth DE; Bousse T
Virology; 2018 Sep; 522():65-72. PubMed ID: 30014859
[TBL] [Abstract][Full Text] [Related]
7. Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Strohmeier S; Solórzano A; Berlanda-Scorza F; Innis BL; García-Sastre A; Palese P; Krammer F; Albrecht RA
Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33440898
[TBL] [Abstract][Full Text] [Related]
8. A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.
Bliss CM; Nachbagauer R; Mariottini C; Cuevas F; Feser J; Naficy A; Bernstein DI; Guptill J; Walter EB; Berlanda-Scorza F; Innis BL; García-Sastre A; Palese P; Krammer F; Coughlan L
EBioMedicine; 2024 Jun; 104():105153. PubMed ID: 38805853
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets.
Yeolekar LR; Guilfoyle K; Ganguly M; Tyagi P; Stittelaar KJ; van Amerongen G; Dhere RM; BerlandaScorza F; Mahmood K
Vaccine; 2020 Sep; 38(40):6280-6290. PubMed ID: 32741671
[TBL] [Abstract][Full Text] [Related]
10. Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.
Prokopenko P; Matyushenko V; Rak A; Stepanova E; Chistyakova A; Goshina A; Kudryavtsev I; Rudenko L; Isakova-Sivak I
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992084
[TBL] [Abstract][Full Text] [Related]
11. A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study.
Nachbagauer R; Krammer F; Albrecht RA
Vaccines (Basel); 2018 Jul; 6(3):. PubMed ID: 30044403
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
Rekstin A; Isakova-Sivak I; Petukhova G; Korenkov D; Losev I; Smolonogina T; Tretiak T; Donina S; Shcherbik S; Bousse T; Rudenko L
Biomed Res Int; 2017; 2017():9359276. PubMed ID: 28210631
[TBL] [Abstract][Full Text] [Related]
13. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.
Kirchenbaum GA; Carter DM; Ross TM
J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834
[TBL] [Abstract][Full Text] [Related]
14. Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens.
Wang M; Wei Y; Pu J; Bing G; Sun Y; Sun H; Wei F; Liu J
Vet Microbiol; 2018 Jul; 220():57-66. PubMed ID: 29885802
[TBL] [Abstract][Full Text] [Related]
15. Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model.
Stepanova E; Krutikova E; Wong PF; Matyushenko V; Bazhenova E; Isakova-Sivak I; Rudenko L
Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33513862
[TBL] [Abstract][Full Text] [Related]
16. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
17. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
18. Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets.
Kiseleva I; Krutikova E; Stepanova E; Donina S; Pisareva M; Krivitskaya V; Rekstin A; Sparrow EG; Torelli G; Rudenko L
Biomed Res Int; 2018; 2018():9695628. PubMed ID: 30246028
[TBL] [Abstract][Full Text] [Related]
19. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
[TBL] [Abstract][Full Text] [Related]
20. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
